Altimmune Inc (ALT)
8.405
+0.36
(+4.41%)
USD |
NASDAQ |
Nov 21, 16:00
8.39
-0.02
(-0.18%)
After-Hours: 06:43
Altimmune Total Assets (Quarterly): 147.86M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 147.86M |
| June 30, 2024 | 173.35M |
| March 31, 2024 | 188.36M |
| December 31, 2023 | 210.64M |
| September 30, 2023 | 166.57M |
| June 30, 2023 | 183.32M |
| March 31, 2023 | 187.08M |
| December 31, 2022 | 206.93M |
| September 30, 2022 | 225.28M |
| June 30, 2022 | 209.91M |
| March 31, 2022 | 205.66M |
| December 31, 2021 | 218.86M |
| September 30, 2021 | 236.91M |
| June 30, 2021 | 257.26M |
| March 31, 2021 | 264.25M |
| December 31, 2020 | 245.12M |
| September 30, 2020 | 233.00M |
| June 30, 2020 | 102.54M |
| March 31, 2020 | 54.23M |
| December 31, 2019 | 54.06M |
| September 30, 2019 | 56.39M |
| June 30, 2019 | 61.98M |
| March 31, 2019 | 65.37M |
| December 31, 2018 | 54.75M |
| September 30, 2018 | 52.86M |
| Date | Value |
|---|---|
| June 30, 2018 | 52.10M |
| March 31, 2018 | 60.87M |
| December 31, 2017 | 63.03M |
| September 30, 2017 | 74.35M |
| June 30, 2017 | 90.84M |
| March 31, 2017 | 20.73M |
| December 31, 2016 | 38.40M |
| September 30, 2016 | 140.54M |
| June 30, 2016 | 27.93M |
| March 31, 2016 | 18.73M |
| December 31, 2015 | 19.86M |
| September 30, 2015 | 20.90M |
| June 30, 2015 | 22.62M |
| March 31, 2015 | 25.47M |
| December 31, 2014 | 21.98M |
| September 30, 2014 | 23.35M |
| June 30, 2014 | 15.22M |
| March 31, 2014 | 14.37M |
| December 31, 2013 | 17.14M |
| September 30, 2013 | 20.62M |
| June 30, 2013 | 24.59M |
| March 31, 2013 | 21.97M |
| December 31, 2012 | 22.74M |
| September 30, 2012 | 23.41M |
| June 30, 2012 | 23.81M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
54.06M
Minimum
Dec 2019
264.25M
Maximum
Mar 2021
188.56M
Average
206.29M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Viking Therapeutics Inc | 937.89M |
| Amgen Inc | 90.88B |
| Avid Bioservices Inc | 334.64M |
| NovaBay Pharmaceuticals Inc | 3.877M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 14.49M |
| Shareholders Equity (Quarterly) | 133.38M |
| Current Ratio | 16.87 |